Keywords: cytogen, gets, fda, approval, market, prostascint, food

Cytogen Gets FDA Approval To Market ProstaScint

Article | 04 November 1996

- The US Food and Drug Administration has given Cytogen clearance to market ProstaScint (capromab pendetide), its monoclonal antibody-based imaging agent. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in